Federation des caisses Desjardins du Quebec’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-35,061
Closed -$771K 2779
2025
Q1
$771K Hold
35,061
﹤0.01% 901
2024
Q4
$795K Hold
35,061
﹤0.01% 849
2024
Q3
$637K Hold
35,061
﹤0.01% 889
2024
Q2
$1.02M Buy
35,061
+6,500
+23% +$193K 0.01% 766
2024
Q1
$1.24M Hold
28,561
0.01% 653
2023
Q4
$1.24M Sell
28,561
-1,320
-4% -$51.9K 0.01% 560
2023
Q3
$1.14M Sell
29,881
-1,839
-6% -$77.4K 0.01% 543
2023
Q2
$1.3M Hold
31,720
0.01% 538
2023
Q1
$1.82M Buy
31,720
+1,990
+7% +$112K 0.02% 429
2022
Q4
$1.67M Buy
29,730
+4,600
+18% +$234K 0.02% 418
2022
Q3
$1.06M Hold
25,130
0.01% 550
2022
Q2
$1.36M Buy
25,130
+3,680
+17% +$221K 0.02% 483
2022
Q1
$1.38M Hold
21,450
0.01% 548
2021
Q4
$1.44M Sell
21,450
-6,290
-23% -$426K 0.01% 543
2021
Q3
$1.9M Buy
+27,740
New +$1.96M 0.02% 489
2019
Q3
Sell
-300
Closed -$16.8K 2303
2019
Q2
$16.8K Buy
+300
New +$15.4K ﹤0.01% 1726

Other funds holding IART

Federation des caisses Desjardins du Quebec's IART Position: Q2 2025 in Review

Federation des caisses Desjardins du Quebec sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 35,061 shares — an estimated $771K sold.

Federation des caisses Desjardins du Quebec first reported a position in IART in Q2 2019 and held it in 16 quarters. The position peaked at $1.9M in Q3 2021. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.

  • Federation des caisses Desjardins du Quebec reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 35,061 Integra LifeSciences shares in Q2 2025, an estimated $771K.
  • Federation des caisses Desjardins du Quebec first reported a position in Integra LifeSciences in Q2 2019 and held it in 16 quarters.
  • Federation des caisses Desjardins du Quebec's Integra LifeSciences position peaked at $1.9M in Q3 2021.
  • 208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2025, filed 14 Aug 2025.